CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To elucidate the metabolic proteome that underlies CML progression, we purified CD34+ stem/progenitor cells from treatment-naive CML as well as normal CD34+ cells and performed label-free quantitative proteomic analysis (Fig. 1A).